Payers we have sourced
- UnitedHealthcareWegovy and Zepbound, varies by plan
- AnthemWegovy and Zepbound, varies by plan
- AetnaZepbound, varies by plan
- CignaWegovy and Zepbound, varies by plan
- HumanaWegovy and Zepbound, depends on the indication
- Kaiser PermanenteWegovy and Zepbound, varies by plan
- ACA MarketplaceGLP-1 medications, not covered
- AmbetterWegovy and Zepbound, depends on the indication
- BCBS IllinoisWegovy, varies by plan
- BCBS IllinoisZepbound, varies by plan
- BCBS South CarolinaZepbound, covered with prior authorization
- Blue Shield of CaliforniaWegovy, varies by plan
- Blue Shield of CaliforniaZepbound, varies by plan
- FEHB / FEP BlueWegovy or Zepbound, covered with prior authorization
- Florida BlueWegovy and Zepbound for weight loss, not covered
- HighmarkZepbound and Wegovy for weight loss, covered with prior authorization
- Independence Blue CrossGLP-1 medications, depends on the indication
- MolinaWegovy and Zepbound, varies by plan
- OscarOzempic, covered with prior authorization
- Premera Blue CrossWegovy, varies by plan
- TRICAREWegovy and Zepbound, covered with prior authorization
- Wellcare MedicareGLP-1 medications, depends on the indication
We publish a coverage page only where we found a published policy document, a federal statute, or independent formulary analysis. That is 22 payer pages today.
GLP-1 insurance coverage by payer puts the insurers we have read in one table, drug by drug.
On Medicare? The GLP-1 Bridge is live: eligible Part D beneficiaries pay a flat $50 a month for Wegovy (injection or pill), Foundayo or the Zepbound KwikPen through December 31, 2027. Who qualifies and what each dose costs, or read the CMS page.
One page per insurer
Each page below covers one insurer and carries its answer for every GLP-1 we have sourced a policy on. Start there if you know your card but not which drug to look up. All 20 live under the coverage checker.
- ACA Marketplace1 GLP-1, read June 12, 2026
- Aetna4 GLP-1s, read August 27, 2026
- Ambetter4 GLP-1s, read August 28, 2026
- Anthem4 GLP-1s, read August 28, 2026
- BCBS Illinois5 GLP-1s, read August 28, 2026
- BCBS South Carolina1 GLP-1, read June 12, 2026
- Blue Shield of California5 GLP-1s, read August 28, 2026
- Cigna4 GLP-1s, read August 27, 2026
- FEHB / FEP Blue1 GLP-1, read August 31, 2026
- Florida Blue4 GLP-1s, read August 28, 2026
- Highmark4 GLP-1s, read August 28, 2026
- Humana4 GLP-1s, read September 7, 2026
- Independence Blue Cross1 GLP-1, read September 7, 2026
- Kaiser Permanente3 GLP-1s, read August 27, 2026
- Molina3 GLP-1s, read August 27, 2026
- Oscar3 GLP-1s, read August 28, 2026
- Premera Blue Cross4 GLP-1s, read August 28, 2026
- TRICARE3 GLP-1s, read August 31, 2026
- UnitedHealthcare4 GLP-1s, read August 27, 2026
- Wellcare Medicare1 GLP-1, read June 12, 2026
Why most commercial coverage varies by plan
About 60 to 80 percent of commercially insured Americans are in self-funded employer plans. The employer bears the drug cost and the insurer only administers the claims, so the employer negotiates its own drug benefit. A UnitedHealthcare or Cigna member whose employer opted out of anti-obesity drugs is denied even if the insurer's standard formulary would cover them.
Employer election is not the only switch. The pharmacy benefit manager can drop a drug from the standard formulary underneath everyone at once, which is what CVS Caremark did to Zepbound on Aetna commercial plans on July 1, 2025. How Aetna covers Zepbound now has the member-side detail: FE-Compatible plans still cover it under policy 6947-C, and the standard commercial series needs an exception under 6981-A.
That is why a page that just says “UnitedHealthcare covers Wegovy” would mislead most readers. UnitedHealthcare covers Wegovy for obesity on plans that include the weight-management benefit, and whether your specific plan includes it depends on your employer. The way to find out is your summary of benefits or the number on your card.
Do not see your payer?
Some large payers, including CareFirst and Horizon, run coverage differently across states and plans, so the answer lives in the tools built for exactly that. The general coverage picture, the prior-authorization process, denial reasons, and the four appeal pathways are in the GLP-1 insurance guide. The prior authorization letter library has 200 templates across 20 plans, and the appeal letter library covers 120 denial scenarios. For Medicaid, see the state-by-state Medicaid coverage table. If you would rather a program run the prior authorization for you, the Calibrate review and the Noom Med review cover how each handles branded coverage.
How we built this
Every page here comes from the payer's own policy, a federal law, or KFF's plan research. Each row links its source and gives the date we read it. Some plan files load at the address the payer gives but will not open. We check those against a second source and mark the row lower confidence. Job-based plans also choose whether to add the weight-drug benefit at all, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.